-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Sn8/CsbQwFLLRbhqmoi1nruSD4/JG/UcDEELAjaIBiX0ZJqjQ8ZwvFaKI8k7np3e sllZmZ6InmcA13aphYrvvg== 0000912057-00-021064.txt : 20010524 0000912057-00-021064.hdr.sgml : 20010524 ACCESSION NUMBER: 0000912057-00-021064 CONFORMED SUBMISSION TYPE: 6-K/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20000419 FILED AS OF DATE: 20000502 FILER: COMPANY DATA: COMPANY CONFORMED NAME: VISIBLE GENETICS INC CENTRAL INDEX KEY: 0001010819 STANDARD INDUSTRIAL CLASSIFICATION: 3826 IRS NUMBER: 000000000 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 6-K/A SEC ACT: SEC FILE NUMBER: 000-28550 FILM NUMBER: 617106 BUSINESS ADDRESS: STREET 1: 700 BAY ST STREET 2: SUITE 1000 CITY: TORONTO ONTARIO CANA STATE: A6 BUSINESS PHONE: 2127025700 MAIL ADDRESS: STREET 1: 700 BAY ST STE 1000 STREET 2: TORONTO ONTARIO CANADA CITY: M5G 1Z6 6-K/A 1 6-K/A-1 - - -------------------------------------------------------------------------------- SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K/A-1 REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13A-16 OR 15D-16 OF THE SECURITIES EXCHANGE ACT OF 1934 FILING NO. 2 FOR THE MONTH OF APRIL, 2000 Visible Genetics Inc. --------------------- (Exact name of Registrant) 700 Bay Street, Suite 1000, Toronto ON, Canada M5G 1Z6 ------------------------------------------------------ (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F. Form 20-F /X/ Form 40-F /_/ Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934. Yes /_/ No /X/ - - -------------------------------------------------------------------------------- VISIBLE GENETICS INC. On or about April 19, 2000, Visible Genetics Inc. (the "Company") mailed a Notice of Annual and Special Meeting of Shareholders, and Management Information Circular and Proxy Statement, each dated April 13, 2000 and Forms of Proxy, each of which was filed by the Company with the SEC on April 19, 2000 under cover of Form 6-K. The Form 6-K filed by the Company on April 19, 2000 incorporated by reference the information set forth therein into the Company's Registration Statements on Form F-3, and into the prospectuses contained therein, (File Nos. 333-67607, 333-68939, 333-91155 and 333-94649) and the Company's outstanding Registration Statements on Form S-8. The Company hereby incorporates the information set forth in the Form 6-K filed by the Company on April 19, 2000 into the Company's Registration Statement on Form F-3 (File No. 333-32258), and into the prospectus contained therein, and into each of the prospectuses included in the Company's outstanding Registration Statements on Form S-8. SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. VISIBLE GENETICS INC. Date: May 2, 2000 By: /s/ Thomas J. Clarke -------------------- Name: Thomas J. Clarke Title: Chief Financial Officer -----END PRIVACY-ENHANCED MESSAGE-----